Graves Disease
Showing 26 - 50 of >10,000
Customized Multiple Orbital Wall Decompression for
Recruiting
- Thyroid Eye Disease
- Modified multiple orbital wall decompression
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital
Nov 17, 2022
A Single-Site Tissue Repository Providing Annotated Biospecimens
Recruiting
- Age-Related Macular Degeneration
- +46 more
- Specimen sample
-
Waltham, MassachusettsSanguine Biosciences
Nov 22, 2022
Graves Ophthalmopathy, Graves Disease, Thyroid-associated Ophthalmopathy Trial in Guangzhou (Doxycycline hyclate, Placebo)
Recruiting
- Graves Ophthalmopathy
- +8 more
- Doxycycline hyclate
- Placebo
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center
Nov 16, 2021
Associated Burden of Related Conditions in Alopecia Areata
Completed
- Alopecia Areata
- +35 more
- Exposure of interest (studies 2 & 3).
-
London, United KingdomMomentum Data Ltd
Dec 13, 2022
Graves Disease Trial in Jinan
Active, not recruiting
- Graves Disease
-
Jinan, Shandong, ChinaShandong Provincial Hospital
Apr 12, 2021
Graves' Disease Trial in Liverpool, Manchester (K1-70 intramuscular or K1-70 intravenous)
Completed
- Graves' Disease
- K1-70 intramuscular or K1-70 intravenous
-
Liverpool, United Kingdom
- +1 more
May 18, 2021
Thyroid Eye Disease Trial in Miami (TOUR006 - 20 MG, Placebo, TOUR006 - 50 MG)
Recruiting
- Thyroid Eye Disease
- TOUR006 - 20 MG
- +2 more
-
Miami, FloridaSite - 0103
Oct 11, 2023
Graves' Disease in Remission (Disorder) Trial in Cheongju-si, Seoul (heart rate monitoring using wearable devices)
Recruiting
- Graves' Disease in Remission (Disorder)
- heart rate monitoring using wearable devices
-
Cheongju-si, Korea, Republic of
- +5 more
Mar 17, 2021
Thyroid Eye Disease, TED Trial in Shanghai (IBI311)
Recruiting
- Thyroid Eye Disease, TED
-
Shanghai, Shanghai, ChinaNinth People's Hospital Affiliated to Shanghai Jiao Tong Univers
Nov 9, 2023
Thyroid Eye Disease Trial in Beijing (ZB001 for injection)
Not yet recruiting
- Thyroid Eye Disease
- ZB001 for injection
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Mar 7, 2023
Thyroid Eye Disease Trial (VRDN-001 10 mg/kg Drug:)
Not yet recruiting
- Thyroid Eye Disease
- VRDN-001 10 mg/kg Drug:
- (no location specified)
Sep 7, 2023
Thyroid Eye Disease Trial in Shanghai (IBI311, )
Recruiting
- Thyroid Eye Disease
- IBI311
- placebo
-
Shanghai, Shanghai, ChinaShanghai Ninth People's Hospital, Shanghai JiaoTong University S
Mar 20, 2023
Untreated Graves' Hyperthyroidism Avoiding Thionamide Drugs With
Completed
- Graves Disease
- Potassium Iodide
- (no location specified)
Dec 24, 2020
Thyroid Eye Disease, Graves Orbitopathy Trial in Germany (Secukinumab, Placebo)
Recruiting
- Thyroid Eye Disease
- Graves Orbitopathy
- Secukinumab
- Placebo
-
Essen, Germany
- +6 more
Jul 14, 2022
Thyroid Goiter Trial (total thyroidectomy, subtotal thyroidectomy)
Not yet recruiting
- Thyroid Goiter
- total thyroidectomy
- subtotal thyroidectomy
- (no location specified)
Oct 2, 2020
Additional Autoimmune Diseases With Type 1 Diabetes in
Enrolling by invitation
- Type 1 Diabetes
- +6 more
- No intervention.
-
Vandoeuvre les nancy, Lorraine, FranceHôpital d'Enfants de Brabois
Mar 26, 2021
Thyroid Eye Disease, Eyelid Diseases Trial in Tel Hashomer (Tamsulosin)
Recruiting
- Thyroid Eye Disease
- Eyelid Diseases
-
Tel Hashomer, IsraelSheba Medical Center
Jun 22, 2022
Thyroid-Associated Ophthalmopathy Trial (Sirolimus 1 mg Oral Tablet, Methylprednisolone)
Not yet recruiting
- Thyroid-Associated Ophthalmopathy
- Sirolimus 1 mg Oral Tablet
- Methylprednisolone
- (no location specified)
Mar 18, 2022
Hyperthyroidism, Autoimmune Trial in Spain (Lugols Strong Iodine)
Recruiting
- Hyperthyroidism, Autoimmune
- Lugols Strong Iodine
-
Hospitalet de Llobregat, Barcelona, Spain
- +20 more
Jul 4, 2021
Thyroid Eye Disease, Graves Orbitopathy, Endocrine System Diseases Trial in Canada, United Kingdom, United States (Linsitinib,
Recruiting
- Thyroid Eye Disease
- +11 more
- Linsitinib
- Placebo
-
Beverly Hills, California
- +22 more
Jan 30, 2023